Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel Stip

Showing results (171-180 of 278) with videos related to

Pageof 28
Sort By:
Schizophrenia (Heidelberg, Germany)|July 19, 2022
Neural alterations of emotion processing in atypical trajectories of psychotic-like experiencesRoxane Assaf, Julien Ouellet, Josiane Bourque, et al.
International Journal of Psychiatry in Clinical Practice|March 20, 2018
The screen for cognitive impairment in psychiatry (SCIP) is associated with disease severity and cognitive complaints in major depressionSmadar Valérie Tourjman, Robert-Paul Juster, Scot Purdon, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|February 19, 2008
Influence of comorbid obsessive-compulsive symptoms on brain event-related potentials in Gilles de la Tourette syndromeGeneviève Thibault, Mihaela Felezeu, Kieron P O'Connor, et al.
Scientific Reports|September 29, 2022
A functional neuroimaging study of self-other processing alterations in atypical developmental trajectories of psychotic-like experiencesRoxane Assaf, Julien Ouellet, Josiane Bourque, et al.
The Journal of Nervous and Mental Disease|March 28, 2023
Can Cotard Syndrome Be Induced?: Illustration With a Rare Case of Potential Organ TransplantEmmanuel Stip, Mohammed AlAhbabi, Danilo Arnone, et al.
Early Intervention in Psychiatry|May 25, 2019
Long-acting antipsychotic medication as first-line treatment of first-episode psychosis with comorbid substance use disorderAmal Abdel-Baki, Dominic Thibault, Sofia Medrano, et al.
Current Medical Research and Opinion|March 16, 2007
Rivastigmine treatment as an add-on to antipsychotics in patients with schizophrenia and cognitive deficitsSylvie Chouinard, Emmanuel Stip, Julie Poulin, et al.
The Journal of Mental Health Policy and Economics|January 4, 2007
Health care resource use associated with integrated psychological treatmentHelen-Maria Vasiliadis, Catherine Briand, Alain Lesage, et al.
Psychiatry Research|September 18, 2012
Sensation-seeking, social anhedonia, and impulsivity in substance use disorder patients with and without schizophrenia and in non-abusing schizophrenia patientsSimon Zhornitsky, Elie Rizkallah, Tania Pampoulova, et al.
Brain and Cognition|August 30, 2005
Cognitive discernible factors between schizophrenia and schizoaffective disorderEmmanuel Stip, Amir Ali Sepehry, Antoinette Prouteau, et al.
Pageof 28

Showing results (171-180 of 278) with videos related to

Sort By:
Pageof 28
Schizophrenia (Heidelberg, Germany)|July 19, 2022
Neural alterations of emotion processing in atypical trajectories of psychotic-like experiencesRoxane Assaf, Julien Ouellet, Josiane Bourque, et al.
International Journal of Psychiatry in Clinical Practice|March 20, 2018
The screen for cognitive impairment in psychiatry (SCIP) is associated with disease severity and cognitive complaints in major depressionSmadar Valérie Tourjman, Robert-Paul Juster, Scot Purdon, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|February 19, 2008
Influence of comorbid obsessive-compulsive symptoms on brain event-related potentials in Gilles de la Tourette syndromeGeneviève Thibault, Mihaela Felezeu, Kieron P O'Connor, et al.
Scientific Reports|September 29, 2022
A functional neuroimaging study of self-other processing alterations in atypical developmental trajectories of psychotic-like experiencesRoxane Assaf, Julien Ouellet, Josiane Bourque, et al.
The Journal of Nervous and Mental Disease|March 28, 2023
Can Cotard Syndrome Be Induced?: Illustration With a Rare Case of Potential Organ TransplantEmmanuel Stip, Mohammed AlAhbabi, Danilo Arnone, et al.
Early Intervention in Psychiatry|May 25, 2019
Long-acting antipsychotic medication as first-line treatment of first-episode psychosis with comorbid substance use disorderAmal Abdel-Baki, Dominic Thibault, Sofia Medrano, et al.
Current Medical Research and Opinion|March 16, 2007
Rivastigmine treatment as an add-on to antipsychotics in patients with schizophrenia and cognitive deficitsSylvie Chouinard, Emmanuel Stip, Julie Poulin, et al.
The Journal of Mental Health Policy and Economics|January 4, 2007
Health care resource use associated with integrated psychological treatmentHelen-Maria Vasiliadis, Catherine Briand, Alain Lesage, et al.
Psychiatry Research|September 18, 2012
Sensation-seeking, social anhedonia, and impulsivity in substance use disorder patients with and without schizophrenia and in non-abusing schizophrenia patientsSimon Zhornitsky, Elie Rizkallah, Tania Pampoulova, et al.
Brain and Cognition|August 30, 2005
Cognitive discernible factors between schizophrenia and schizoaffective disorderEmmanuel Stip, Amir Ali Sepehry, Antoinette Prouteau, et al.
Pageof 28